Rising Incidence of Hemophilia, Immunological Disorders, and the Growing Number of Surgical Procedures Worldwide is Driving Growth, at a CAGR of ~9%Dublin, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The "Blood ...

Spanish plasma-derived medicines specialist Grifols revealed it is collaborating with Dutch biotechnology start-up, FcR ...

The Europe In Vitro Diagnostics (IVD) market plays a crucial role in the region’s healthcare landscape, encompassing a wide range of diagnostic tests and technologies used for disease detection, ...

Global in vitro diagnostics (IVD) market will reach $148,393.3 million by 2031, growing by 6.3% annually over 2021-2031. The global in vitro diagnostics (IVD) market encompasses a wide range of ...

Grifols, a global healthcare company and leading manufacturer of plasma-derived medicines, has announced a collaboration with ...

For decades, Grifols grew rich from an empire built on blood. Founded by a plucky scientist and his two sons in the years after the Spanish Civil War, the company made a series of breakthroughs that ...

European equities traded in the US as American depositary receipts were treading water late Monday morning, edging 0.04% higher to 1,357.59 on the S&P Europe Select ADR Index. From continental Europe, ...

Judge José Luis Calama of the National Court, who is investigating the Grifols case, has asked the National Securities Market Commission ...

Michael J. Fox was diagnosed with Parkinson’s disease at 29 years old — just one year after the “Back to the Future” trilogy ...

The global hepatitis diagnostic test market is poised for significant growth, with market value projected to increase from USD 3621.5 million in 2024 to USD 6118.4 million by 2033, reflecting a steady ...

Some of Grifols SA ’s board members could be sanctioned for the Spanish drug maker’s accounting deficiencies as the company readies to face off short seller Gotham City Research in a Madrid court.